DUSP9 and hepatoblastoma: Interestingly, ginkgolic acid was found to be a potent antitumor agent in several solid tumors, suggesting its therapeutic potential for the treatment of cancer [84,88,89] This suggests its putative use in tumors overexpressing DUSP9 such as C2 or C2A hepatoblastomas.